| J9271 | Injection, pembrolizumab, 1 mg | 33,000 | $40 | $1.4M |
| J0897 | Injection, denosumab, 1 mg | 9,420 | $20 | $179K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,320 | $110 | $146K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 580 | $160 | $93.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 500 | $140 | $69.1K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 820 | $80 | $66.6K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 7,720 | $10 | $46.3K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 250 | $70 | $17.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 16,330 | $1 | $16.3K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 210 | $70 | $13.8K |